Treatment outcome in adults with chronic fatigue syndrome: a prospective study in England based on the CFS/ME National Outcomes Database.
Crawley, E, Collin, S M, White, P D et al. · QJM : monthly journal of the Association of Physicians · 2013 · DOI
Quick Summary
This study tracked over 800 people with ME/CFS who received care at NHS specialist services in England for 8-20 months. Patients showed meaningful improvements in fatigue, physical function, anxiety, depression, and pain. The study found that patients who started with more severe fatigue, disability, or pain tended to have less improvement, suggesting baseline severity is an important predictor of how well someone will improve with specialist care.
Why It Matters
This is one of the few real-world studies measuring outcomes in NHS ME/CFS specialist services, providing evidence that patients can expect clinically meaningful improvements from specialist care. Understanding which baseline factors predict poor outcomes helps clinicians identify patients who may need more intensive or modified interventions.
Observed Findings
Mean fatigue improved by 6.8 points on the Chalder Fatigue Scale (statistically significant)
Physical function improved by 4.4 points on SF-36 (statistically significant)
Anxiety and depression both significantly decreased at follow-up
Pain reduced by an average of 5.3 points on visual analogue scale
Baseline severity of fatigue, disability, and pain independently predicted worse fatigue outcomes at follow-up
Inferred Conclusions
Patients attending NHS specialist CFS/ME services experience clinically meaningful improvements comparable to those in cognitive behavioural therapy and graded exercise therapy trials
Physical function improvement may be more limited in real-world specialist services compared to controlled trial settings
Baseline symptom severity and disability are important predictive factors for treatment response
Specialist assessment and care can produce improvements across multiple symptom domains including fatigue, mood, and pain
Remaining Questions
Which specific treatments or care components within NHS specialist services most effectively drive fatigue and pain improvement?
What This Study Does Not Prove
This study does not establish causation or identify which specific treatments drove the improvements observed. The lack of a control group means we cannot determine whether improvements resulted from NHS care, natural disease progression, or other factors. The 49% loss to follow-up and absence of data on individual treatment protocols limit generalizability of findings.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionMixed Cohort
Why do patients in specialist services show less physical function improvement than those in controlled trials, and what modifications might improve this?
Do improvements persist beyond 20 months, and are there patterns of relapse or sustained recovery?
Which baseline factors or patient characteristics identify those who might need alternative or enhanced treatment approaches?